66 related articles for article (PubMed ID: 1690346)
1. [Immunohistochemical study using a double fluorescent staining on the regional lymph nodes of gastric cancers].
Chono S
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):36-46. PubMed ID: 1690346
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study of the regional lymph nodes in gastric cancer].
Okabayashi T
Nihon Geka Gakkai Zasshi; 1987 May; 88(5):529-42. PubMed ID: 3110588
[TBL] [Abstract][Full Text] [Related]
3. [An immunohistochemical study using a double staining method for regional lymph nodes in gastric cancer].
Chohno S; Horimi T; Okabayashi T; Mukai K; Takeda I; Kaneda M; Tokuda N; Tanaka I; Miyake N; Orita K
Gan No Rinsho; 1987 Nov; 33(14):1793-7. PubMed ID: 2447306
[TBL] [Abstract][Full Text] [Related]
4. [A clinical study of immunological status in gastric cancer patients--with special reference to T-cell subsets in the lymphocytes of regional lymph nodes].
Ohwada S; Takeshita M; Miyamoto Y; Izumi M
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1560-6. PubMed ID: 2263239
[TBL] [Abstract][Full Text] [Related]
5. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
[TBL] [Abstract][Full Text] [Related]
6. [Effect of endoscopic local injection of OK-432 on regional lymph nodes in gastric cancer patients].
Ogawara T; Sakai K; Sekikawa T; Kouno K; Matsumoto Y
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1601-4. PubMed ID: 1530316
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of immunological response of regional lymph node lymphocytes from patients with gastric cancer after endoscopic local injection of biological response modifier (BRM)].
Obi Y
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):293-302. PubMed ID: 2051981
[TBL] [Abstract][Full Text] [Related]
8. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
9. Identification and importance of lymphocyte subpopulations in the regional lymph nodes of breast cancer patients.
Khuri N; Jothy SP; Shibata HR
Can J Surg; 1989 Jan; 32(1):23-6. PubMed ID: 2463069
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study on lymphocyte subsets of sentinel lymph nodes in breast cancer patients].
Wang S; Fan P; Wu ZY
Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):220-2. PubMed ID: 15312384
[TBL] [Abstract][Full Text] [Related]
11. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
Kobayashi G
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
[TBL] [Abstract][Full Text] [Related]
12. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
13. [Distribution of lymphocyte subpopulation and natural killer activity in gastric cancer tissue, normal stomach and various tissues of gastric cancer patients].
Moritani Y
Nihon Geka Gakkai Zasshi; 1984 Feb; 85(2):132-42. PubMed ID: 6611484
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tissue lymphocytes by double fluorescent staining--gastric cancer tissue and regional lymph nodes.
Takeda I; Horimi T; Okabayashi T; Nagae S; Chono S; Tokuda N; Orita K
Jpn J Surg; 1987 May; 17(3):156-61. PubMed ID: 3306074
[TBL] [Abstract][Full Text] [Related]
15. CD8+CD11b+ peripheral blood T lymphocytes contain lymphokine-activated killer cell precursors.
Dianzani U; Zarcone D; Pistoia V; Grossi CE; Pileri A; Massaia M; Ferrarini M
Eur J Immunol; 1989 Jun; 19(6):1037-44. PubMed ID: 2502419
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
Damle NK; Doyle LV; Bradley EC
J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
[TBL] [Abstract][Full Text] [Related]
17. [A clinical study of immunological status in patients with gastric cancer: with special reference to T-cell subsets, interleukin-2 in the lymphocytes of peripheral blood].
Owada S
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):52-61. PubMed ID: 2138244
[TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneity of CD4+ T lymphocytes: two subpopulations with counteracting immunoregulatory functions identified with the monoclonal antibodies WR16 and WR19.
Moore K; Nesbitt AM
Immunology; 1987 Jun; 61(2):159-65. PubMed ID: 2954898
[TBL] [Abstract][Full Text] [Related]
19. Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line.
Yokoyama H; Nakanishi H; Kodera Y; Ikehara Y; Ohashi N; Ito Y; Koike M; Fujiwara M; Tatematsu M; Nakao A
Clin Cancer Res; 2006 Jan; 12(2):361-8. PubMed ID: 16428473
[TBL] [Abstract][Full Text] [Related]
20. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
